Markets signal approval of Sanofi’s Genzyme tilt – Reuters

Markets signal approval of Sanofi's Genzyme tiltReutersPA) shares, sparked broker upgrades and is backed by very cheap debt. A stock rally since the Sanofi chief executive made his approach public has added …and more »